To Compare and Evaluate the Effect of Duchenne Muscular Dystrophy affected Patients Undergoing Current TreatmentAlong with Food Supplements
Not Applicable
Completed
- Conditions
- Health Condition 1: M638- Disorders of muscle in diseases classified elsewhere
- Registration Number
- CTRI/2021/05/033346
- Lead Sponsor
- ichiIn Biosciences Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 28
Inclusion Criteria
1. Subject who diagnosed with DMD
2. Aged from 6-18
3. Patients who are to participate in the study with a written inform consent form.
Exclusion Criteria
Subjects who are not a part of any clinical studies prior to 30 days.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Observation of changes in the levels of IL-6 and Myoglobin urea from the baseline.Timepoint: Day 45±1
- Secondary Outcome Measures
Name Time Method 1. Measurement of the levels of CK, Titin, TNF, Haptoglobin, Dystrophin level, LFT,CBC,Cystatin C <br/ ><br>2. Immunological Parameters: IL-13,CD-40,ESR <br/ ><br>Timepoint: Day 1, Day21 ± 1, Day 45±1 and Monitoring Adverse events each visits <br/ ><br>